retatrutide trial weight loss Retatrutide: Phase 3 Results (Up to 28.7% Loss), Mechanism, Trials & 2026 Updates Lilly's triple agonist delivers up

Key findings include: TRIUMPH-4 Trial : Participants with obesity and knee osteoarthritis experienced substantial weight loss and pain reduction

However, recent guidelines now recommend a more flexible approach, especially for patients with cardiovascular disease or high-risk profiles

Wegovy (semaglutide) is FDA-approved specifically for chronic weight management in adults meeting certain criteria

Managing nausea with fiber Nausea is the most common GLP-1 side effect overall, and fiber supplements can either help or hurt depending on how they are used

239 Liraglutide mediated a significant decrease in CV mortality whereas exenatide reduced nonfatal stroke in diabetic patients

One large trial found that participants who tapered off semaglutide gained back 94% of their lost weight within 12 months, while those who continued treatment maintained 75% of their initial weight loss